The envelope glycoprotein of small ruminant lentiviruses (SRLV) is a major target of the humoral immune response and contains several linear B-cell epitopes. We amplified and sequenced the genomic segment encoding the SU5 antigenic site of the envelope glycoprotein of several SRLV field isolates. With synthetic peptides based on the deduced amino acid sequences of SU5 in an enzyme-linked immunosorbent assay (ELISA), we have (i) proved the immunodominance of this region regardless of its high variability, (ii) defined the epitopes encompassed by SU5, (iii) illustrated the rapid and peculiar kinetics of seroconversion to this antigenic site, and (iv) shown the rapid and strong maturation of the avidity of the anti-SU5 antibody. Finally, we demonstrated the modular diagnostic potential of SU5 peptides. Under Swiss field conditions, the SU5 ELISA was shown to detect the majority of infected animals and, when applied in a molecular epidemiological context, to permit rapid phylogenetic classification of the infecting virus.Caprine arthritis-encephalitis virus (CAEV) of goats and maedi-visna virus (MVV) of sheep belong to the genus Lentivirus of the family Retroviridae (18,22,39). Strong evidence indicates that cross-species transmission from sheep to goats and vice versa occurs under field conditions (16, 24, 33). Therefore, these viruses are no longer considered to be species specific and are referred to as small-ruminant lentiviruses (SRLV).The majority of infected animals mount a strong immune response to these viruses but remain persistently infected. Only one-third of infected goats develop overt clinical disease, and in sheep the percentage of animals with clinical symptoms differs greatly between breeds, strongly suggesting that, in both species, genetic factors play a key role in determining the clinical outcome of infection (11,28,29).In several countries, eradication programs have been initiated to control SRLV-induced diseases with the aim of eliminating these viruses (23). The Swiss CAEV eradication program, initiated in 1984, has reduced the seroprevalence from 60 to 80% to less than 1% and eliminated clinical cases in the goat population (14, 15). However, in the last phase of the eradication program, detection and elimination of the remaining virus carriers appear to be very difficult. The serological tools currently used (37, 38) are of limited use when applied to screen a population with a low seroprevalence. In the absence of reliable tools to directly detect SRLV, consistent serological diagnoses depend on the costly use of a combination of tests run in parallel (4). Major problems in SRLV serology are slow seroconversions and low titers of antibody to Gag in some animals. In this respect, the strong immunogenicity of the envelope glycoprotein (Env) and especially the rapid seroconversion induced by this antigen in infected animals make it an ideal candidate for diagnostic applications (2, 19). Goats and sheep infected with SRLV develop high titers of antibodies to several conformational and linear ...